Erratum to “Inflammation and Its Role in Prostate Cancer” [Journal of Cancer Therapy 5 (2014) 836-844]


Inflammation is associated with various cancers, and plays a significant role in prostate cancer genesis including initiation, promotion, malignant conversion, invasion, and metastasis. While several studies posit an important role of inflammation in prostate growth, the exact mechanisms are not known. The extant basic and clinical research in the area, trying to unravel the etiology of prostatic inflammation and its signaling pathway, may help to develop novel therapeutic interventions against prostate cancer development triggered by inflammation.

Share and Cite:

Mishra, R. and Tewari, A. (2015) Erratum to “Inflammation and Its Role in Prostate Cancer” [Journal of Cancer Therapy 5 (2014) 836-844]. Journal of Cancer Therapy, 6, 109-113. doi: 10.4236/jct.2015.61011.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Albini, A. and Sporn, M. (2007) The Tumour Microenvironment as a Target for Chemoprevention. Nature Reviews Cancer, 7, 139-147.
[2] Abate, S. and Shen, M. (2000) Molecular Genetics of Prostate Cancer. Genes Development, 14, 2410-2434.
[3] Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M. and Boyle, P. (2007) Estimates of the Cancer Incidence and Mortality in Europe. Annals of Oncology, 18, 581-592.
[4] Pisani, P., Parkin, M., Munoz, N. and Ferlay, J. (1997) Cancer and Infection: Estimates of the Attributable Fraction in 1990. Cancer Epidemiology, Biomarkers Prevention, 6, 387-400.
[5] Klein, E. and Silverman, R. (2008) Inflammation, Infection, and Prostate Cancer. Current Opinion in Urology, 18, 315-319.
[6] Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? Lancet, 357, 539-545.
[7] Nelson, W, Sfanos, K., DeMarzo, A. and Yegnasubramanian, S. (2013) Prostate Inflammation and Prostate Cancer. Management of Prostate Cancer, 4, 103-115.
[8] Lee, J., Demissie, K., Lu, S. and Rhoads, G. (2007) Cancer Incidence among Korean-American Immigrants in the United States and Native Koreans in South Korea. Cancer Control, 14, 78-85.
[9] Sfanos, K. and Marzo, M. (2012) Prostate Cancer and Inflammation: The Evidence. Histopathology, 60, 199-215.
[10] Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancer-Related Inflammation. Nature, 454, 436-444.
[11] Chughtai, B., Lee, R., Te, A. and Kaplan, S. (2011) Role of Inflammation in Benign Prostatic Hyperplasia. Reviews in Urology, 13, 147-150.
[12] Fibbi, B., Penna, G., Morelli, A., Adorini, L. and Maggi, M. (2010) Chronic Inflammation in the Pathogenesis of Benign Prostatic Hyperplasia. International Journal of Andrology, 33, 475-488.
[13] Koopmann, W. and Krangel, M. (1997) Identification of a Glycosaminoglycan-Binding Site in Chemokine Macrophage Inflammatory Protein-1α. The Journal of Biological Chemistry, 272, 10103-10109.
[14] Coussens, L.M. and Werb, Z. (2002) Inflammation and Cancer. Nature, 420, 860-867.
[15] Shacter, E. and Weitzman, S. (2002) Chronic Inflammation and Cancer. Oncology, 16, 217-226.
[16] Jackson, R., Seed, M., Kircher, C., Willoughby, D. and Winkler, J. (1997) The Codependence of Angiogenesis and Chronic Inflammation. FASEB Journal, 11, 457-465.
[17] Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F. and Loguercio, C. (2007) Chronic Inflammation and Oxidative Stress in Human Carcinogenesis. International Journal of Cancer, 121, 2381-2386.
[18] Sies, H. (1997) Oxidative Stress: Oxidants and Antioxidants. Experimental Physiology, 82, 291-295.
[19] Finkel, T. and Holbrook, N. (2000) Oxidants, Oxidative Stress and the Biology of Ageing. Nature, 408, 239-247.
[20] Naber, K. and Weidner, W. (2000) Chronic Prostatitis—An Infectious Disease? Journal of Antimicrobial Chemotherapy, 46, 157-161.
[21] Sugar, L. (2006) Inflammation and Prostate Cancer. Canadian Journal of Urology, 13, 46-47.
[22] Josson, S., Matsuoka, Y., Chung, L., Zhau, H. and Wang, R. (2010) Tumor-Stroma Co-Evolution in Prostate Cancer Progression and Metastasis. Seminars in Cell & Developmental Biology, 21, 26-32.
[23] Sun, S., Sprenger, C., Vessella, R., Haugk, K., Soriano, K., Mostaghel, E., Page, S., Coleman, I., Nguyen, H., Sun, H., Nelson, P. and Plymate, S. (2010) Castration Resistance in Human Prostate Cancer Is Conferred by a Frequently Occurring Androgen Receptor Splice Variant. Journal of Clinical Investigation, 120, 2715-2730.
[24] Nguyen, D., Li, J., Yadav, S. and Tewari, A. (2013) Recent Insights into NF-κB Signalling Pathways and the Link between Inflammation and Prostate Cancer. BJU International, 4, 23-28.
[25] Karin, M. and Lin, A. (2009) NF-κB at the Crossroads of Life and Death. Nature Immunology, 3, 221-227.
[26] Stock, D., Groome, A. and Siemens, R. (2008) Inflammation and Prostate Cancer. A Future Target for Prevention and therapy? Urologic Clinics of North America, 35, 117-130.
[27] Shukla, S., MacLennan, G., Marengo, R., Resnick, M. and Gupta, S. (2004) Nuclear Factor κB/p65 (Rel A) Is Constitutively Activated in Human Prostate Adenocarcinoma and Correlates with Disease Progression. Neoplasia, 6, 390-400.
[28] Suh, J., Payvandi, F., Edelstein, L., Amenta, P., Zong, W., Gélinas, C. and Rabson, A. (2002) Mechanisms of Constitutive NF-κB Activation in Human Prostate Cancer Cells. The Prostate, 52, 183-200.
[29] Pahl, H. (1999) Activators and Target Genes of Rel/NF-κB Transcription Factors. Oncogene, 18, 6853-6866.
[30] Mantovani, A. (2009) Cancer: Inflaming Metastasis. Nature, 457, 36-37.
[31] Pollard, J. (2004) Tumour-Educated Macrophages Promote Tumour Progression and Metastasis. Nature Reviews Cancer, 4, 71-78.
[32] Locksley, R., Killeen, N. and Lenardo, M. (2001) The TNF and TNF Receptor Superfamilies: Integrating Mammalian Biology. Cell, 104, 487-501.
[33] Nakashima, J., Tachibana, M., Ueno, M., Miyajima, A., Baba, S. and Murai, M. (1998) Association between Tumor Necrosis Factor in Serum and Cachexia in Patients with Prostate Cancer. Clinical Cancer Research, 4, 1743-1748.
[34] Irie, A., Lee, K., Kadowaki, K., Toda, K. and Yamada, Y. (1999) Elevation of Serum and Urine Tumor Necrosis Factor Levels after Transurethral Resection of the Prostate. Nippon Hinyokika Gakkai Zasshi, 90, 502-508.
[35] Nakajima, Y., Dellipizzi, A., Mallouh, C. and Ferreri, N. (1996) TNF-Mediated Cytotoxicity and Resistance in Human Prostate Cancer Cell Lines. The Prostate, 6, 296-302.
[36] Davis, J., Nastiuk, K. and Krolewski, J. (2012) TNF Is Necessary for Castration-Induced Prostate Regression, Whereas TRAIL and FasL Are Dispensable. The Journal of Clinical Endocrinology and Metabolism, 96, 873.
[37] Alcover, J., Filella, X., Luque, P., Molina, R., Izquierdo, L., Maria, J. and Alcaraz, A. (2010) Prognostic Value of IL-6 in Localized Prostatic Cancer. Anticancer Research, 30, 4369-4372.
[38] Nguyen, D., Li, J. and Tewari, A. (2013) Inflammation and Prostate Cancer: The Role of Interleukin-6. BJU International, Published Online.
[39] Chung, Y. and Chang, Y. (2003) Serum Interleukin-6 Levels Reflect the Disease Status of Colorectal Cancer. Journal of Surgical Oncology, 83, 222-226.
[40] Shariat, S., Chromecki, T., Hoefer, J., Barbieri, C., Scherr, D., Karakiewicz, P., Roehrborn, C., Montorsi, F., Culig, Z. and Cavarretta, T. (2011) Soluble gp130 Regulates Prostate Cancer Invasion and Progression in an Interleukin-6 Dependent and Independent Manner. The Journal of Urology, 186, 2107-2114.
[41] Deeble, P., Murphy, D., Parsons, S. and Cox, M. (2001) Interleukin-6- and Cyclic AMP-Mediated Signaling Potentiates Neuroendocrine Differentiation of LNCaP Prostate Tumor Cells. Molecular and Cellular Biology, 21, 8471-8482.
[42] Joseph, L., Jian, Z., Jill, A. and Evan, T. (2011) The PCa Tumor Microenvironment. Cancer Microenviron- ment, 4, 283-297.
[43] Blaszczyk, N., Masri, B., Mawji, N., Ueda, T., McAlinden, G., Duncan, C., Bruchovsky, N., Schweikert, H., Schnabel, D., Jones, E. and Sadar, M. (2004) Osteoblast-Derived Factors Induce Androgen-Independent Proliferation and Expression of Prostate-Specific Antigen in Human Prostate Cancer Cells. Clinical Cancer Research, 10, 1860-1869.
[44] Kosaka, T., Miyata, A., Ihara, H., Hara, S., Sugimoto, T., Takeda, O., Takahashi, E. and Tanabe, T. (1994) Characterization of the Human Gene (PTGS2) Encoding Prostaglandin-Endoperoxide Synthase 2. European Journal of Biochemistry, 221, 889-897.
[45] Van der Giet, M., Tolle, M. and Kleuser, B. (2008) Relevance and Potential of Sphingosine-1-Phosphate in Vascular Inflammatory Disease. Biological Chemistry, 389, 1381-1390.
[46] McCarty, M. (2004) Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy. Integrative & Complementary Medicine, 3, 349-380.
[47] Mahmud, S., Franco, E. and Aprikian, A. (2004) Prostate Cancer and Use of Nonsteroidal Anti-Inflammatory Drugs: Systematic Review and Meta-Analysis. British Journal of Cancer, 90, 93-99.
[48] Inoue, K., Slaton, J., Eve, B., Kim, S., Perrotte, P., Balbay, M., Yano, S., Bar-Eli, M., Radinsky, R., Pettaway, C. and Dinney, C. (2000) Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-Independent Prostate Cancer. Clinical Cancer Research, 6, 2104-2119
[49] Uehara, H., Troncoso, P., Johnston, D., Bucana, C., Dinney, C., Dong, Z., Fidler, I. and Pettaway, C. (2005) Expression of Interleukin-8 Gene in Radical Prostatectomy Specimens Is Associated with Advanced Pathologic Stage. The Prostate, 64, 40-49.
[50] Steiner, G., Newman, M., Paikl, D., Stix, U., Memaran-Dagda, N., Lee, C. and Marberger, M. (2003) Expression and Function of Pro-Inflammatory Interleukin IL-17 and IL-17 Receptor in Normal, Benign Hyperplastic, and Malignant Prostate. The Prostate, 56, 171-182.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.